BioMarin Hints Probable Delay For US Approval For Roctavian, But Analyst Convinced For Transformative 2023
Biomarin Pharmaceutical Inc (NASDAQ:BMRN) reported a break-even in Q4 FY22 compared to a loss of $(0.32) a year ago and the…
El-Erian Says Congress Should Enhance Fed’s Accountability, Require It To Follow Bank Of England’s Example
Allianz chief economic adviser and noted economist Mohamed El-Erian said he believes Congress should enhance the Federal Reserve‘s…
Li Auto Analyst Reacts To China EV Player’s Q4 Earnings Beat: ‘Expect 2023 To Turn Profitable’
Li Auto Inc (NASDAQ: LI) shares traded slightly lower on Monday morning after the Chinese electric vehicle maker reported a first-quarter earnings beat, but Bank of America analyst Ming Hsun Lee said there's plenty of upside ahead for Li shares.
Analyst Says This Small Cap Biotech Firm Has ‘Very Valuable Therapeutic,’ Upgrades Stock
Raymond James has upgraded Dyne Therapeutics Inc (NASDAQ:DYN) from Outperform to Strong Buy and raised the price target to $27 from $16.…
Nordstrom Analyst Remains Cautious On Limited Near-Term Visibility; Expects Growth To Moderate In FY23
Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating on the shares of Nordstrom Inc (NYSE:JWN) with a price target…
Cars.com Is Firing On All Cylinders, Says This Analyst
Barrington Research analyst Gary Prestopino reiterated an Outperform rating on the shares of Cars.com Inc (NYSE: CARS) with a price target of $25.
ACM Research’s Repeated Upbeat Quarterly Results, Record Shipments, Product Launches & Order Win Impress Analysts
Needham analyst Quinn Bolton reiterated ACM Research Inc (NASDAQ:ACMR) with a Buy and raised the price target from $12 to $15. ACMR…
Willis Towers Watson Gets Upgrade From Goldman Sachs As Analyst Sees Turnaround By 2HFY23
Goldman Sachs analyst Robert Cox upgraded Willis Towers Watson (NASDAQ: WTW) from Neutral to Buy
ChatGPT Opportunity Could Be ‘Tens Of Billions Of Dollars Annually’ For Nvidia: Why This Analyst Is Bullish
Technology giant Nvidia Corporation (NASDAQ: NVDA) is one of the companies that could benefit from increased use of chatbots like ChatGPT, according to a new analyst note.
Analyst Cautions Investors On Overreacting To ‘Early-Stage’ Pfizer/Seagen Discussions
In a news article by the Wall Street Journal, Pfizer Inc (NYSE:PFE) is reportedly in early-stage talks to acquire Seagen Inc (NASDAQ:SGEN) for…